| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/29/1998 | EP0837951A1 Antisense inhibition of hepatitis b virus replication |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 04/29/1998 | EP0837932A1 Macrophage activating factors derived from cloned vitamin d binding protein |
| 04/29/1998 | EP0837929A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 04/29/1998 | EP0837928A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 04/29/1998 | EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES |
| 04/29/1998 | EP0837859A1 Tetrahydrofuran antifungals |
| 04/29/1998 | EP0837845A1 Herpes ribonucleotide reductase inhibitors |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837695A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep |
| 04/29/1998 | EP0837692A1 Clostridium difficile toxins as mucosal adjuvants |
| 04/29/1998 | EP0837630A1 Prodrugs of pharmaceuticals with improved bioavailability |
| 04/29/1998 | EP0722448A4 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CN1179948A Antiviral antibacterial traditional Chinese medicine compound preparation |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744621 Cis-epoxide compounds |
| 04/28/1998 | US5744601 Cyclization of aminomalonic ester with guanidine; chlorination; reacting with aqueous solution of carboxylic acid |
| 04/28/1998 | US5744596 Antivirus agent |
| 04/28/1998 | US5744481 β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/28/1998 | US5744478 Thiazolo 3,2-a! quinoline and thiazolo 3,2-a! naphthyridine derivatives |
| 04/28/1998 | US5744465 Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems |
| 04/28/1998 | US5744461 Viricides |
| 04/28/1998 | US5744338 DNA encoding seryl tRNA synthetase from Staphylococcus aureus |
| 04/28/1998 | US5744144 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744142 Self-assembling recombinant papillomavirus capsid proteins |
| 04/28/1998 | US5744141 Flavivirus recombinant poxvirus immunological composition |
| 04/28/1998 | US5744140 Recombinant poxvirus containing forein dna from encephalitis virus protein m or virus protein e, ns1, and ns2a |
| 04/28/1998 | CA2118937C Triazole antifungal agents |
| 04/28/1998 | CA2102859C Expression vector for phytolacca antiviral protein |
| 04/28/1998 | CA2076650C Roquinimex for treating hiv infections |
| 04/23/1998 | WO1998016834A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | WO1998016626A1 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 04/23/1998 | WO1998016558A1 METHOD FOR PRODUCING AN IgM PREPARATION FOR INTRAVENOUS ADMINISTRATION |
| 04/23/1998 | WO1998016555A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 04/23/1998 | WO1998016553A1 Bordetella strain expressing the fha hybrid, liposomes and vaccines |
| 04/23/1998 | WO1998016552A1 Helicobacter pylori live vaccine |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016515A1 Compounds and methods to treat infectious diseases |
| 04/23/1998 | WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016504A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998016111A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 04/23/1998 | WO1998016104A1 Antimicrobial lipids |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | WO1998007429A3 Antifungal composition with enhanced bioavailability |
| 04/23/1998 | CA2268904A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268875A1 Antimicrobial lipids |
| 04/23/1998 | CA2268103A1 Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268033A1 Helicobacter pylori live vaccine |
| 04/23/1998 | CA2268011A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 04/23/1998 | CA2268008A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2267233A1 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2266848A1 Method for producing an igm preparation for intravenous application |
| 04/22/1998 | EP0837138A2 Novel topoisomerase III |
| 04/22/1998 | EP0837137A2 Novel topoisomerase III |
| 04/22/1998 | EP0837136A2 Novel topoisomerase I |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837130A2 M protein analogue from Streptococcus pneumoniae |
| 04/22/1998 | EP0836648A1 Recombinant mva virus, and the use thereof |
| 04/22/1998 | EP0836647A2 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/22/1998 | EP0836619A1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 04/22/1998 | EP0836617A1 Parevins and tachytegrins |
| 04/22/1998 | EP0836482A1 Subunit vaccine against flavivirus infection |
| 04/22/1998 | EP0836477A1 Antibacterial synergistic composition comprising rifabutin |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179722A Combination therapy for HIV infection using HIV protease inhibitor indinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 04/22/1998 | CN1179718A Novel pharmaceutical composition |
| 04/22/1998 | CA2214677A1 Cephalosporin pyridinium derivatives |
| 04/21/1998 | US5741902 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741808 Protein kinase inhibitors for treatmen of neurological disorders |
| 04/21/1998 | US5741782 Mixture of bactericide and fungicide; decontaminating tissue for transplantation |
| 04/21/1998 | US5741775 Antibiotic and antifungal agents |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/21/1998 | US5741656 Epstein-Barr virus sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 04/21/1998 | US5741494 Immunopotentiative and infection-protective agent containing bacillus and egg white |
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/16/1998 | WO1998015658A1 Compositions and methods for treating viral infections |
| 04/16/1998 | WO1998015637A1 Herpes simplex virus strains |
| 04/16/1998 | WO1998015631A1 Attenuated microorganism strains expressing hpv proteins |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |